Phase 2 Trial Completes Dosing First OC Patient with Aivita’s Cell Therapy
News
A Phase 2 trial exploring Aivita Biomedical’s cell therapy AVOVA-1 for ovarian cancer has treated its first patient and continues to recruit participants across eight sites in the United States. So far, ... Read more